At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 120 enrolled
Drug / intervention
ultrasound guided injection of local anesthetic between the popliteal artery and the capsule of the knee (iPACK)drug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Analgesic Efficacy of Adding the IPACK Block to a Multimodal Analgesia Protocol for Primary Total Knee Arthroplasty
In Brief
A Phase 3 clinical trial evaluating ultrasound guided injection of local anesthetic between the popliteal artery and the capsule of the knee (iPACK) for Knee Arthroplasty, Total. Completed, enrolled 120 participants across 1 site.
Detailed Summary
This is a perspective, randomized, blinded study with a parallel design and an allocation ratio of 1 to 1 for the treatment groups to assess the analgesic efficacy of adding the iPACK (injection between the popliteal artery and the capsule of the knee) in addition to the adductor canal block (ACB) for Total Knee Arthoplasty patients (TKA).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsKnee Arthroplasty, Total
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
20192020202120222023202420252026
Enrollment StartJul 2018
First PostedOct 2018
Primary CompletionAug 2019
Study CompletionAug 2021
TodayJul 2026
First PostedOct 11, 2018
Enrollment StartJul 1, 2018
Primary CompletionAug 27, 2019
Study CompletionAug 27, 2021
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 7.7 years ago
Interventions
ultrasound guided injection of local anesthetic between the popliteal artery and the capsule of the knee (iPACK)drug
nerve block for posterior knee pain after a TKA.